Active	Status	Sponsor type	Region	Phase	Filter
18 Active 12 Inactive 30 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

18 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Werida, Rehab
NCT05881720: Sacubitril/Valsartan Versus Valsartan in Heart Failure	Completed	4	80	RoW	Sacubitril / Valsartan Oral Tablet, sacubitril / valsartan (100 mg twice daily), Valsartan 80 mg, Valsartan	Damanhour University, Tanta University	Heart Failure	06/23	06/23
NCT05459701: Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)	Completed	4	50	RoW	Dapagliflozin 10mg Tab, Dapagliflozin 10 mg., Placebo	Rehab Werida, University of Alexandria	Nonalcoholic Fatty Liver Disease, Type 2 Diabetes	06/24	07/24
NCT05830981: Valproic Acid Use in Patients With Neurological Disorders	Completed	N/A	600	NA	Educational intervention, Educational &counselling sessions	Damanhour University, Mansoura University	Neurological Disorders	12/17	12/17
NCT05857176: Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.	Completed	N/A	508	RoW	COVID-19 Vaccine questionnaire, Google form questionnaire	Damanhour University, Alexandria University	COVID-19 Vaccine Adverse Reaction	02/22	02/22
NCT05916105: Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting	Completed	N/A	151	RoW	Ciprofloxacin Tablets, Ciprofloxacin	Damanhour University	Ciprofloxacin Adverse Reaction	02/22	03/22
NCT05291039: Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.	Completed	N/A	56	RoW	Infliximab, IFX, Adalimumab, ADA	Rehab Werida	Inflammatory Bowel Diseases	03/23	04/23
NCT05289349: Propofol or Sevoflurane Anesthesia in Egyptian Patients	Completed	N/A	44	RoW	Propofol, Sevoflurane, Sevoflurane inhalant product	Rehab Werida	Anesthesia	03/23	04/23
NCT05291338: Pharmacogenetic Study in Hepatocellular Carcinoma Patients.	Completed	N/A	107	RoW	Doxorubicin, Adriamycin, Lipiodol, ethiodized oil	Rehab Werida	Hepatocellular Carcinoma	03/23	04/23
NCT05459389: Early Targeted Antibiotic Therapy in Patients With Sepsis	Completed	N/A	48	RoW	targeted antibiotics therapy, genotyping	Rehab Werida	Sepsis	08/23	09/23
NCT06065280: Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF Patients	Completed	N/A	80	RoW	Empagliflozin 10 MG, Jardiance 10 mg, Dapagliflozin 10 MG, Forxiga 10 mg	Damanhour University	Heart Failure, Reduced Ejection Fraction Heart Failure	12/24	12/24
NCT06068686: Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients	Completed	N/A	70	RoW	Vildagliptin 50 MG, Vildagliptin, Glimepiride 3 Mg Oral Tablet, Amaryl	Damanhour University	Type 2 Diabetes	11/24	12/24
NCT06030895: Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.	Completed	N/A	100	RoW	Sorafenib Tablets, Nexavar	Damanhour University, Mransoura University	Hepatocellular Carcinoma	02/24	03/24
NCT06056687: Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy	Completed	N/A	60	RoW	Alpha Lipoic Acid 600 MG Oral Tablet, Thiotacid 600 mg, Placebo Tablet, Placebo	Damanhour University	Ischemic Cardiomyopathy, Diabetes Mellitus	01/24	02/24
NCT05813145: Fenofibrate Role in Breast Cancer Patients	Completed	N/A	50	NA	Placebo, Placebo tablet, Fenofibrate 160mg, Lipanthyl 16omg	Damanhour University	Breast Cancer	08/24	08/24
NCT06068673: The Potential Impact of Clindamycin on Neurosurgery Patients.	Completed	N/A	44	RoW	Clindamycin 600 mg, Dalacin 600 mg, standard regimen, Placebo	Damanhour University	Neurologic Complication, Neurosurgery	12/23	12/23
NCT05959889: Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer	Completed	N/A	50	RoW	Placebo, Placebo tablet, Montelukast, Montelukast tablet	Damanhour University	Breast Cancer, Doxorubicin Induced Cardiotoxicity	11/24	12/24
NCT06661980: Dexmedetomidine on Brain Injury Patients	Recruiting	N/A	60	RoW	Dexmedetomidine Injectable Solution, Dexmedetomidine, Placebo, NS	Damanhour University, Tanta University	Brain Injuries	11/25	12/25
NCT06661993: Alpha-lipoic Acid in Critically Ill Patients With Sepsis	Recruiting	N/A	60	RoW	Placebo, placebo film-coated tablet, Alpha-lipoic acid, Thiotacid 1800 mg	Damanhour University, Tanta University	Sepsis	10/25	11/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Werida, Rehab
NCT05881720: Sacubitril/Valsartan Versus Valsartan in Heart Failure	Completed	4	80	RoW	Sacubitril / Valsartan Oral Tablet, sacubitril / valsartan (100 mg twice daily), Valsartan 80 mg, Valsartan	Damanhour University, Tanta University	Heart Failure	06/23	06/23
NCT05459701: Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)	Completed	4	50	RoW	Dapagliflozin 10mg Tab, Dapagliflozin 10 mg., Placebo	Rehab Werida, University of Alexandria	Nonalcoholic Fatty Liver Disease, Type 2 Diabetes	06/24	07/24
NCT05830981: Valproic Acid Use in Patients With Neurological Disorders	Completed	N/A	600	NA	Educational intervention, Educational &counselling sessions	Damanhour University, Mansoura University	Neurological Disorders	12/17	12/17
NCT05857176: Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.	Completed	N/A	508	RoW	COVID-19 Vaccine questionnaire, Google form questionnaire	Damanhour University, Alexandria University	COVID-19 Vaccine Adverse Reaction	02/22	02/22
NCT05916105: Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting	Completed	N/A	151	RoW	Ciprofloxacin Tablets, Ciprofloxacin	Damanhour University	Ciprofloxacin Adverse Reaction	02/22	03/22
NCT05291039: Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.	Completed	N/A	56	RoW	Infliximab, IFX, Adalimumab, ADA	Rehab Werida	Inflammatory Bowel Diseases	03/23	04/23
NCT05289349: Propofol or Sevoflurane Anesthesia in Egyptian Patients	Completed	N/A	44	RoW	Propofol, Sevoflurane, Sevoflurane inhalant product	Rehab Werida	Anesthesia	03/23	04/23
NCT05291338: Pharmacogenetic Study in Hepatocellular Carcinoma Patients.	Completed	N/A	107	RoW	Doxorubicin, Adriamycin, Lipiodol, ethiodized oil	Rehab Werida	Hepatocellular Carcinoma	03/23	04/23
NCT05459389: Early Targeted Antibiotic Therapy in Patients With Sepsis	Completed	N/A	48	RoW	targeted antibiotics therapy, genotyping	Rehab Werida	Sepsis	08/23	09/23
NCT06065280: Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF Patients	Completed	N/A	80	RoW	Empagliflozin 10 MG, Jardiance 10 mg, Dapagliflozin 10 MG, Forxiga 10 mg	Damanhour University	Heart Failure, Reduced Ejection Fraction Heart Failure	12/24	12/24
NCT06068686: Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients	Completed	N/A	70	RoW	Vildagliptin 50 MG, Vildagliptin, Glimepiride 3 Mg Oral Tablet, Amaryl	Damanhour University	Type 2 Diabetes	11/24	12/24
NCT06030895: Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.	Completed	N/A	100	RoW	Sorafenib Tablets, Nexavar	Damanhour University, Mransoura University	Hepatocellular Carcinoma	02/24	03/24
NCT06056687: Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy	Completed	N/A	60	RoW	Alpha Lipoic Acid 600 MG Oral Tablet, Thiotacid 600 mg, Placebo Tablet, Placebo	Damanhour University	Ischemic Cardiomyopathy, Diabetes Mellitus	01/24	02/24
NCT05813145: Fenofibrate Role in Breast Cancer Patients	Completed	N/A	50	NA	Placebo, Placebo tablet, Fenofibrate 160mg, Lipanthyl 16omg	Damanhour University	Breast Cancer	08/24	08/24
NCT06068673: The Potential Impact of Clindamycin on Neurosurgery Patients.	Completed	N/A	44	RoW	Clindamycin 600 mg, Dalacin 600 mg, standard regimen, Placebo	Damanhour University	Neurologic Complication, Neurosurgery	12/23	12/23
NCT05959889: Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer	Completed	N/A	50	RoW	Placebo, Placebo tablet, Montelukast, Montelukast tablet	Damanhour University	Breast Cancer, Doxorubicin Induced Cardiotoxicity	11/24	12/24
NCT06661980: Dexmedetomidine on Brain Injury Patients	Recruiting	N/A	60	RoW	Dexmedetomidine Injectable Solution, Dexmedetomidine, Placebo, NS	Damanhour University, Tanta University	Brain Injuries	11/25	12/25
NCT06661993: Alpha-lipoic Acid in Critically Ill Patients With Sepsis	Recruiting	N/A	60	RoW	Placebo, placebo film-coated tablet, Alpha-lipoic acid, Thiotacid 1800 mg	Damanhour University, Tanta University	Sepsis	10/25	11/25